netter-2: 177lu-dotatate in gastroenteropancreatic nets
Published 2 months ago • 79 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:57
177lu-dotatate in patients with well-differentiated, high-grade nets
-
1:59
netter-1 update: 177lu-dotatate in patients with midgut neuroendocrine tumors
-
4:25
final os from netter-1: lutetium-177-dotatate in patients with midgut nets
-
0:56
lu177 prrt for neuroendocrine tumors nets
-
42:10
clinical nuclear medicine | prrt, lutathera and netter 1 trial
-
1:03
dr. strosberg on retreatment with 177lu-dotatate in advanced nets
-
5:52
netter-1 clinical trial overview
-
1:47
dr. chauhan on the role of 177lu-dotatate in nets
-
4:27
living with neuroendocrine cancer – meet rachael
-
5:53
neuroendocrine tumours (nets): symptoms, diagnosis and treatment
-
2:18
neuroendocrine tumor (gallium-68 dotatate pet/ct)
-
3:09
new treatment for neuroendocrine tumors
-
2:34
clinical trial: lutathera® (lutetium lu 177 dotatate) for brain tumor (nct05278208)
-
6:59
recently approved drugs: lutetium lu 177 dotatate for treatment of gep-nets
-
1:41
dr. jonathan r. strosberg on 177-lu-dotatate in patients with neuroendocrine tumors
-
2:13
understanding neuroendocrine tumors
-
1:19
dr. strosberg on future of 177lu-dotatate therapy in neuroendocrine tumors
-
3:47
how prrt can improve care for neuroendocrine tumor patients
-
2:15
dr. wolin on the safety profile of lutathera in advanced nets
-
0:49
dr. strosberg on fda approval of lutathera for gep-nets
-
2:00
raquel wagman, md: a new treatment for patients with gep-nets
-
1:54
unanswered questions in gastrointestinal neuroendocrine tumors